BACKGROUND: Patients with end-stage renal disease (ESRD) are known to have impaired immune function. Dendritic cells (DCs) are the major antigen-presenting cells that initiate primary immune responses, linking innate and adaptive immunity. Although suboptimal immune responses to vaccination, as frequently observed in ESRD patients, might suggest the presence of impaired DC function, the precise nature of altered DC function is not fully understood. METHODS: In the current study, we compared the maturation status, viability, and function of monocyte-derived DCs (moDCs) of patients on hemodialysis (HD) with healthy controls. RESULTS: Surface expression of major histocompatibility complex class II, CD83, and CD86, and chemokine receptor CCR7 in moDCs was not different between HD patients and healthy controls. No significant difference was detected in the viability of moDCs determined by expression of annexin V and propidium iodide between two groups. However, moDCs from HD patients produced significantly higher amounts of IL-6 when stimulated by cytokine cocktails compared to healthy controls. In addition, mature moDCs from HD patients showed significantly enhanced allogeneic T-cell proliferation compared to healthy controls. CONCLUSIONS: Our data demonstrate aberrant DC function in HD patients and suggest that this might contribute to impaired immune responses.
BACKGROUND:Patients with end-stage renal disease (ESRD) are known to have impaired immune function. Dendritic cells (DCs) are the major antigen-presenting cells that initiate primary immune responses, linking innate and adaptive immunity. Although suboptimal immune responses to vaccination, as frequently observed in ESRDpatients, might suggest the presence of impaired DC function, the precise nature of altered DC function is not fully understood. METHODS: In the current study, we compared the maturation status, viability, and function of monocyte-derived DCs (moDCs) of patients on hemodialysis (HD) with healthy controls. RESULTS: Surface expression of major histocompatibility complex class II, CD83, and CD86, and chemokine receptor CCR7 in moDCs was not different between HDpatients and healthy controls. No significant difference was detected in the viability of moDCs determined by expression of annexin V and propidium iodide between two groups. However, moDCs from HDpatients produced significantly higher amounts of IL-6 when stimulated by cytokine cocktails compared to healthy controls. In addition, mature moDCs from HDpatients showed significantly enhanced allogeneic T-cell proliferation compared to healthy controls. CONCLUSIONS: Our data demonstrate aberrant DC function in HDpatients and suggest that this might contribute to impaired immune responses.
Authors: K Raska; J Raskova; S M Shea; R M Frankel; R H Wood; J Lifter; I Ghobrial; R P Eisinger; L Homer Journal: Am J Med Date: 1983-11 Impact factor: 4.965
Authors: Dennis A Hesselink; Michiel G H Betjes; Martijn A Verkade; Petros Athanassopoulos; Carla C Baan; Willem Weimar Journal: Nephrol Dial Transplant Date: 2005-05-10 Impact factor: 5.992
Authors: Hye Won Kim; Young Seok Woo; Ha Na Yang; Hye Min Choi; Sang Kyung Jo; Won Yong Cho; Hyoung-Kyu Kim Journal: Clin Exp Nephrol Date: 2010-12-09 Impact factor: 2.801
Authors: Martijn Anton Verkade; Corné Johan van Druningen; Leonard Maria Bernardus Vaessen; Dennis Adriaan Hesselink; Willem Weimar; Michiel Gerardus Henricus Betjes Journal: Nephrol Dial Transplant Date: 2006-09-27 Impact factor: 5.992
Authors: Hanan Fouad; Maissa Saeed El Raziky; Rasha Ahmed Abdel Aziz; Dina Sabry; Ghada Mahmoud Abdel Aziz; Manal Ewais; Ahmed Reda Sayed Journal: World J Gastroenterol Date: 2013-11-21 Impact factor: 5.742
Authors: Ines Rama; Ines Llaudó; Pere Fontova; Gema Cerezo; Carlos Soto; Casimiro Javierre; Miguel Hueso; Nuria Montero; Alberto Martínez-Castelao; Juan Torras; Josep M Grinyó; Josep M Cruzado; Nuria Lloberas Journal: PLoS One Date: 2016-10-26 Impact factor: 3.240